BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32298379)

  • 21. Elevated IL-17A levels in early stages of bladder cancer regardless of smoking status.
    Doroudchi M; Saidi M; Malekzadeh M; Golmoghaddam H; Khezri A; Ghaderi A
    Future Oncol; 2013 Feb; 9(2):295-304. PubMed ID: 23414478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis.
    Njei B; McCarty TR; Birk JW
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1141-6. PubMed ID: 26749521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of elevated levels of C-reactive protein and hypoalbuminemia on survival in patients with advanced inoperable esophageal cancer undergoing palliative treatment.
    Lindenmann J; Fink-Neuboeck N; Koesslbacher M; Pichler M; Stojakovic T; Roller RE; Maier A; Anegg U; Smolle J; Smolle-Juettner FM
    J Surg Oncol; 2014 Nov; 110(6):645-50. PubMed ID: 24975677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of treatment modality in outcomes for different stages of resectable esophageal adenocarcinomas.
    Allan BJ; Pedroso F; Gennis ER; Livingstone AS; Montero A; Lally B; Ardalan B; Koniaris LG; Solomon NL; Franceschi D
    Ann Surg Oncol; 2013 May; 20(5):1660-7. PubMed ID: 23456314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
    Matsui D; Zaidi AH; Martin SA; Omstead AN; Kosovec JE; Huleihel L; Saldin LT; DiCarlo C; Silverman JF; Hoppo T; Finley GG; Badylak SF; Kelly RJ; Jobe BA
    Oncotarget; 2016 Dec; 7(49):81281-81291. PubMed ID: 27793030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
    Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
    Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemoradiation induces epithelial-to-mesenchymal transition in esophageal adenocarcinoma.
    Steins A; Ebbing EA; Creemers A; van der Zalm AP; Jibodh RA; Waasdorp C; Meijer SL; van Delden OM; Krishnadath KK; Hulshof MCCM; Bennink RJ; Punt CJA; Medema JP; Bijlsma MF; van Laarhoven HWM
    Int J Cancer; 2019 Nov; 145(10):2792-2803. PubMed ID: 31018252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of tumor IL-6 expression after preoperative chemoradiotherapy in patients with advanced esophageal squamous cell carcinoma.
    Yoneda M; Fujiwara H; Furutani A; Ikai A; Tada H; Shiozaki A; Komatsu S; Kubota T; Ichikawa D; Okamoto K; Konishi H; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Ochiai T; Otsuji E
    Anticancer Res; 2013 Jun; 33(6):2699-705. PubMed ID: 23749929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D-mannose: a novel prognostic biomarker for patients with esophageal adenocarcinoma.
    Gu J; Liang D; Pierzynski JA; Zheng L; Ye Y; Zhang J; Ajani JA; Wu X
    Carcinogenesis; 2017 Feb; 38(2):162-167. PubMed ID: 28062409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-17A, IL-22, IL-6, and IL-21 Serum Levels in Plaque-Type Psoriasis in Brazilian Patients.
    de Oliveira PS; Cardoso PR; Lima EV; Pereira MC; Duarte AL; Pitta Ida R; Rêgo MJ; Pitta MG
    Mediators Inflamm; 2015; 2015():819149. PubMed ID: 26351408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulatory Tumor Cells in Esophageal Adenocarcinoma.
    Gopalan V; Lam AK
    Methods Mol Biol; 2018; 1756():177-186. PubMed ID: 29600370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of autologous and homologous blood transfusion on interleukins and tumor necrosis factor-α in peri-operative patients with esophageal cancer.
    Xing YL; Wang YC
    Asian Pac J Cancer Prev; 2014; 15(18):7831-4. PubMed ID: 25292072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated IL-17A and IL-22 regulate expression of inducible CD38 and Zap-70 in chronic lymphocytic leukemia.
    Kouzegaran S; Siroosbakht S; Farsad BF; Rezakhaniha B; Dormanesh B; Behnod V; Tanha AS
    Cytometry B Clin Cytom; 2018 Jan; 94(1):143-147. PubMed ID: 27718514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of Interleukin-17A and Interleukin-17E in multiple myeloma patients.
    Lemancewicz D; Bolkun L; Jablonska E; Czeczuga-Semeniuk E; Kostur A; Kloczko J; Dzieciol J
    Med Sci Monit; 2012 Jan; 18(1):BR54-59. PubMed ID: 22207110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma IL-6 and IL-17A Correlate with Severity of Motor and Non-Motor Symptoms in Parkinson's Disease.
    Green HF; Khosousi S; Svenningsson P
    J Parkinsons Dis; 2019; 9(4):705-709. PubMed ID: 31524180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genes of the interleukin-18 pathway are associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma.
    Babar M; Ryan AW; Anderson LA; Segurado R; Turner G; Murray LJ; Murphy SJ; Johnston BT; Comber H; Reynolds JV; McManus R
    Am J Gastroenterol; 2012 Sep; 107(9):1331-41. PubMed ID: 22664470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon gamma, interleukin-6, and -17a levels were correlated with minimal hepatic encephalopathy in HBV patients.
    Li W; Li N; Wang R; Li Q; Wu H
    Hepatol Int; 2015 Apr; 9(2):218-23. PubMed ID: 25794550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma.
    Meaney CL; Zingone A; Brown D; Yu Y; Cao L; Ryan BM
    Oncotarget; 2017 Jun; 8(25):40946-40957. PubMed ID: 28402963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined impact of hepatitis C virus genotype 1 and interleukin-6 and tumor necrosis factor-α polymorphisms on serum levels of pro-inflammatory cytokines in Brazilian HCV-infected patients.
    Tarragô AM; da Costa AG; Pimentel JP; Gomes ST; Freitas FB; Lalwani P; de Araújo AR; Victória Fda S; Victória MB; Vallinoto AC; Sadahiro A; Teixeira-Carvalho A; Martins-Filho OA; Malheiro A
    Hum Immunol; 2014 Nov; 75(11):1075-83. PubMed ID: 25193024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical Management of Early-Stage Esophageal Adenocarcinoma Based on Lymph Node Metastasis Risk.
    Newton AD; Predina JD; Xia L; Roses RE; Karakousis GC; Dempsey DT; Williams NN; Kucharczuk JC; Singhal S
    Ann Surg Oncol; 2018 Jan; 25(1):318-325. PubMed ID: 29147928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.